ReviewPravention und Gesundheitsforderung2022
[What can registries contribute to health services research?]
Review in Pravention und Gesundheitsforderung, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prospective, longitudinal oncology registries enabling advanced real-world evidence: the iOMEDICO experience.ESMO real world data and digital oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Registries are structured collections of data from a prespecified group of patients. Registry data from patients treated in routine clinical care can be used to answer numerous questions, ranging from clinical to health services research. Objectives: This article provides an overview of key applications of registry data. Materials and methods: Three key applications of registry data are illustrated based on an exploratory search of published literature. Results: Registry data create transparency regarding patients and treatments in routine care, e.g., use and effectiveness of treatment outside of clinical trials, where patients are often older and have comorbidities. Hence, registries can be key for quality assurance of patient care. In addition, they allow long-term observation of patients and identification of rare side effects. Registries are a key tool for health services research to generate hypotheses, e.g., concerning the optional treatment of specific groups of patients for whom no randomized controlled clinical trials have been conducted. Furthermore, risk profiles and prognostic scores can be developed using registry data. Finally, application of registry data has also recently become a topic of discussion for regulatory filings during approval and benefit assessments of novel treatments when evidence from clinical trials is considered insufficient. Conclusion: Numerous questions concerning optimal patient care cannot be answered with randomized controlled clinical trials alone. High quality, prospectively collected registry data can fill this gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.